Article

  • The EMBO Journal (1998) 17, 4086 - 4091
  • doi:10.1093/emboj/17.14.4086

The yeast galactose genetic switch is mediated by the formation of a Gal4p–Gal80p–Gal3p complex

Adam Platt1 and Richard J Reece1

  1. School of Biological Sciences, The University of Manchester, 2.205 Stopford Building, Oxford Road, Manchester M13 9PT, UK

Correspondence to:

Richard J Reece, E-mail: Richard.Reece@man.ac.uk

Received 14 April 1998; Accepted 22 May 1998; Revised 20 May 1998


Saccharomyces cerevisiae responds to galactose as the sole source of carbon by activating the GAL genes encoding the enzymes of the Leloir pathway. Here, we show in vitro that the switch from repressed to activated gene expression involves the interplay of three proteins [an activator (Gal4p), a repressor (Gal80p) and an inducer (Gal3p)] and two small molecules (galactose and ATP). We also show that the galactose- and ATP-dependent interaction between Gal3p and Gal80p occurs without disruption of the Gal80p–Gal4p interaction. Thus, Gal3p-mediated activation of transcription occurs via the formation of a tripartite protein complex.


  • Keywords:

    • Gal4p,
    • galactose,
    • gene regulation,
    • genetic switch,
    • in vitro transcription

Introduction

Top

The response of a yeast cell to being challenged with galactose as the sole carbon source is to rapidly activate expression of the GAL genes, by several thousand-fold (Johnston, 1987; Lohr et al., 1995; Reece and Platt, 1997). This activation is dependent on Gal4p, a prototypical transcriptional activator (Hashimoto et al., 1983). Gal4p is bound upstream of the GAL genes in a variety of carbon sources, and its transcriptional activity is controlled by a negative regulator, Gal80p (Nogi et al., 1984; Giniger et al., 1985), which interacts directly with the activation domain of Gal4p to inhibit its activity (Lue et al., 1987; Wu et al., 1996). How is this repressed state overcome when the yeast are grown on galactose? Some clues to this process have been gained from the analysis of the GAL3 gene product. Mutations in this gene lead to a slow induction of GAL gene expression with gal3 yeast cells reaching full expression 3–5 days after the addition of galactose to the culture (Rotman and Spiegelman, 1953). Gal3p shares high sequence homology to galactokinase, Gal1p, but does not possess a galactokinase activity itself (Bhat et al., 1990). Over-production of either Gal3p or Gal1p in yeast cells gives rise to galactose-independent GAL gene expression (Bhat and Hopper, 1991, 1992). Therefore, Gal3p is thought to play a direct role in the process of induction, and Gal1p is able to at least partially complement this function. Recent data have shown that Gal80p and Gal3p interact with each other in a galactose-dependent fashion (Suzuki-Fujimoto et al., 1996; Zenke et al., 1996; Blank et al., 1997; Yano and Fukasawa, 1997). The association between the two proteins is also dependent upon a nucleotide, although nucleotide hydrolysis is not essential (Zenke et al., 1996). The effect of the Gal80p–Gal3p interaction on the ability of Gal4p to activate transcription has not been investigated.

Does the interaction between Gal80p and Gal3p allow Gal4p-mediated transcription to occur? To address this question, and to discern the fate of Gal80p upon induction, we have established the galactose genetic switch in vitro. By addition of Gal3p to a reconstituted transcription reaction containing Gal4p and Gal80p, we demonstrate the ability of Gal3p to mediate galactose induction of transcription in vitro in a galactose-dependent manner. Furthermore, the galactokinase, Gal1p, is shown to functionally substitute, albeit weakly, for Gal3p in the induction process in vitro. Mutant versions of Gal3p and Gal80p are used to demonstrate the specificity and galactose dependency of Gal3p in galactose induction. Finally, we show Gal3p regulation of galactose induction is mediated by the formation of a tripartite complex consisting of Gal4p, Gal80p and Gal3p.

In vitro transcription with Gal4p, Gal80p and Gal3p

We have previously described the purification of functional truncated versions of Gal4p (comprising the DNA-binding domain fused to the activation, and Gal80p interaction, domain) (Reece et al., 1993). Figure 1A shows Gal80p, Gal3p and Gal1p purified from yeast cells. These proteins were used to modulate the transcriptional activity of Gal4p using a yeast nuclear extract-based in vitro transcription system (Wu et al., 1996) (Figure 1B). Gal4p activates transcription approx10-fold using this system, and this activity is specifically inhibited by approximately equimolar amounts of Gal80p (Figure 1B, lanes 2 and 3). Gal3p has no effect on the basal level of transcription (Figure 1B, lane 5) or on the transcriptional activity of Gal4p in the absence of Gal80p (Figure 1B, lane 4), but increasing amounts of Gal3p relieve the inhibitory effect of Gal80p on Gal4p (Figure 1B lanes 6–10). We note that a 20- to 30-fold molar excess of Gal3p over Gal80p is required to alleviate Gal80p repression. The in vitro transcription experiments of Figure 1B were performed presence of 1.5 mM galactose. The presence or absence of galactose has no effect on either the basal or activated levels of transcription generated by Gal4p (data not shown).

Figure 1.

Figure 1 :

Gal3p and Gal1p alleviate Gal80p repression in vitro. (A) Purified fractions (100 ng) of Gal80p, Gal80G152Dp, Gal3p, Gal3cp and Gal1p were separated by SDS–PAGE and stained with Coomassie brilliant blue. The size of the molecular weight markers (lanes 1 and 7), expressed in kDa, are indicated. (B) Gal3p alleviates the repression of Gal80p on Gal4p in vitro. In vitro transcription and primer extension reactions were performed as described previously (Wu et al., 1996) using pG5E4 as a template, shown above the figure. Reactions contained 12 nM Gal4p [amino acids 1–93 fused to 768–881 (Reece et al., 1993)] and 15 nM Gal80p as indicated. Gal3p was present at the concentrations shown. All reactions contained 1.5 mM galactose. (C) Gal1p alleviates the repression of Gal80p on Gal4p in vitro. Reactions contained 12 nM Gal4p, 15 nM Gal80p and Gal1p as indicated. Galactose was added to a final concentration of 1.5 mM where indicated.

View full figure (38 KB)

Gal1p is able to relieve Gal80p repression

The galactokinase, Gal1p, is able to activate the Gal4p–Gal80p complex in vitro in a galactose-dependent manner. It has previously been shown that over-production of Gal1p in vivo promotes galactose-independent expression of the GAL genes (Bhat and Hopper, 1992). We tested the ability of Gal1p to activate Gal4p–Gal80p complex in vitro (Figure 1C. Like Gal3p, Gal1p has no effect on the ability of Gal4p to activate transcription in the absence of Gal80p (Figure 1C, lane 4). Increasing amounts of Gal1p will, however, promote activation of a Gal4p–Gal80p complex in the presence of galactose (Figure 1C, lanes 5–9). At the highest concentration of Gal1p tested (15 muM; Figure 1C, lane 9) we observe approx50% of the transcriptional activity of Gal4p alone as determined by phosphoimage analysis. This level of Gal1p corresponds to a 40-fold molar excess compared with the amount of Gal3p required to achieve the same level of transcriptional activity (Figure 1B). In the absence of galactose we are unable to observe Gal1p-mediated activation of Gal4p–Gal80p (Figure 1C, lane 10).

Galactose-dependent relief of transcriptional repression

The ability of Gal3p to relieve the inhibitory effect of Gal80p on Gal4p is dependent upon galactose. Decreasing the amount of galactose in the transcription reactions reduces the ability of Gal3p to influence the inhibitory activity of Gal80p (Figure 2A lanes 4–10). To test the specificity of the effect of galactose on the ability of Gal3p to influence transcription, we used a constitutive mutant of Gal3p, Gal3cp. Gal3cp is derived from the GAL3c-322 mutation (Asp368Val) which activates GAL gene expression in the absence of galactose in vivo, and constitutively interacts with Gal80p in vitro (Blank et al., 1997). We find that Gal3cp relieves Gal80p-mediated repression of Gal4p activity in the absence of galactose (Figure 2B, lane 10). Low levels of galactose, however, stimulate the ability of Gal3cp to relieve Gal80p repression approx2-fold (Figure 2B, lanes 5–9). The effect of galactose on the activity of Gal3p and Gal3cp are represented graphically in Figure 2C. It is clear that very low concentrations of galactose (50 muM) promote full activity of Gal3cp, whereas a 30-fold higher concentration of galactose is required to promote full activity of the wild-type protein.

Figure 2.

Figure 2 :

The influence of galactose on (A) Gal3p and (B) Gal3cp function. In vitro transcription reactions contained, where indicated, 12 nM Gal4p, 15 nM Gal80p, 1.0 muM Gal3p and 1.0 muM Gal3cp. The final concentration of galactose in each reaction is indicated. (C) A comparison of the effect of galactose on Gal3p and Gal3cp. Phosphoimage analysis was used to quantitate the major E4 extension product. Relative activation is expressed as a percentage of the activation observed in the presence of 1.5 mM galactose.

View full figure (38 KB)

We are unable to test the effect of ATP on the ability of Gal3p to relieve Gal80p-mediated repression of Gal4p activity using this in vitro transcription system since ATP is required for transcription itself. In the presence of 1.5 mM galactose, ATP at a concentration of 1 mM allows full relief of Gal80p repression by Gal3p (data not shown).

Gal80p mutants

Mutant versions of Gal80p respond appropriately in the in vitro transcription system. We investigated two mutants of Gal80p. The first, Gal80G152Dp, was isolated as a null allele of the GAL80 gene (see Materials and methods). This protein will only repress Gal4p-mediated transcription when present at a concentration 20-fold greater than the wild-type protein (Figure 3A, compare lanes 3–5 and 6–8). The second Gal80p mutant has an uninducible phenotype. Gal80S-2p (Glu351 converted to Lys) (Nogi and Fukasawa, 1984) is able to interact with, and repress the transcriptional activity of, Gal4p indistinguishably from wild-type Gal80p (Figure 3A, compare lanes 3–5 and 9–11). Gal80S-2p is, however, refractory to the effect of Gal3p (Figure 3B, lane 7) or Gal3cp (Figure 3B, lane 8).

Figure 3.

Figure 3 :

The effect of Gal80p mutants on transcription in vitro. All reactions contained 12 nM Gal4p. (A) Gal80 proteins were added at concentrations indicated. Galactose and additional ATP were not included in the transcription reactions. (B) Reactions contained 15 nM Gal80p, 12 nM Gal80s-2p, 1.0 muM Gal3p and 1.0 muM Gal3cp as indicated. Galactose was added to a final concentration of 1.5 mM.

View full figure (33 KB)

Gal4p–Gal80p–Gal3p complex formation

How does Gal3p exert its effect on the Gal4p–Gal80p complex? We investigated this using an electrophoretic mobility shift assay (Figure 4). Gal4p forms a complex with DNA in this assay (Figure 4, lane 5) that is further retarded upon addition of Gal80p (Figure 4, lane 7). Gal3cp does not bind DNA itself (Figure 4, lane 2) and has no effect on a Gal4p–DNA complex (Figure 4, lane 6) but will interact with a Gal4p–Gal80p complex and retard its mobility further (Figure 4, lanes 8 and 9). Approximately the same amount of Gal3cp, relative to the concentration of Gal4p and Gal80p, is required to observe the formation of this complex as is needed to observe transcriptional activation of Gal4p–Gal80p (Figure 2). In the absence of either galactose or ATP, the efficiency of formation of the Gal4p–Gal80p–Gal3cp complex is diminished (Figure 4, lanes 10–12). The absence of either galactose or ATP reduces Gal4p–Gal80p–Gal3cp complex formation by 30–35% (Figure 4, lanes 10 and 11). In the absence of both galactose and ATP, formation of the tripartite complex is reduced by 50% (Figure 4, compare lane 9 with 12).

Figure 4.

Figure 4 :

Gal3p forms a complex with Gal4p–Gal80p in the presence of galactose and ATP. Electrophoretic mobility shift assay showing the formation of a Gal4p–Gal80p–Gal3p complex. Assays were performed as described previously (Reece and Ptashne, 1993) using a double-stranded oligonucleotide containing a single Gal4p recognition site. Reactions, containing as indicated Gal4p (150 nM), Gal80p (124 nM) and Gal3cp in the presence or absence of ATP (1 mM) and galactose (1%).

View full figure (64 KB)

We have found that wild-type Gal3p precipitates when electrophoretic mobility shift assays are loaded onto polyacrylamide gels. We have therefore been unable to observe an interaction between wild-type Gal3p and the Gal4p–Gal80p complex. Attempts to identify suitable buffer conditions where this precipitation does not occur have been unsuccessful (data not shown). Gal3cp is able to promote activation of a Gal4p–Gal80p complex as efficiently as wild-type Gal3p (Figure 2) and therefore we believe that the Gal4p–Gal80p–Gal3p complex represents the induced state.

Discussion

Top

These data, together with previous results, suggest a model for the yeast galactose genetic switch (Figure 5). Gal4p is bound to DNA upstream of its target genes and, in the absence of galactose, its transcriptional activity is repressed by Gal80p. The binding of ATP and galactose to Gal3p promotes its association with Gal80p (Suzuki-Fujimoto et al., 1996; Zenke et al., 1996; Blank et al., 1997; Yano and Fukasawa, 1997). We show that this interaction results in the activation of transcription. The association of Gal3p with Gal80p does not dissociate Gal80p from Gal4p, but rather results in the formation of a tripartite Gal4p–Gal80p–Gal3p complex. The fate of Gal80p upon induction of the Gal4p–Gal80p complex has been the focus of much debate. Genetic evidence suggests that the two proteins remain associated after induction (Leuther and Johnston, 1992), but the precise destination of Gal80p remains unresolved (Yano and Fukasawa, 1997). Our data suggest that, upon interaction with Gal3p, Gal80p undergoes a conformational change to release the activation domain of Gal4p such that it can interact with its targets within the transcriptional machinery. It is conceivable that Gal80p dissociates from Gal4p but is held in the complex by Gal3p. Such a model would necessitate direct interaction between Gal3p and Gal4p. We do not observe this interaction (Figure 4, lane 6), but it is possible that it only occurs in the presence of Gal80p, and our assays would not distinguish between these different complexes.

Figure 5.

Figure 5 :

Diagrammatic representation of galactose induction. In the absence of galactose, the transcriptional activity of Gal4p is inhibited by Gal80p. The association of galactose and ATP with Gal3p promote its interaction with the Gal4p–Gal80p complex. This interaction allows Gal4p to be freed from Gal80p inhibition and activate transcription.

View full figure (72 KB)

How does the transcriptional activation domain of Gal4p become available to the transcriptional machinery? Perhaps the simplest mechanism to explain the available data would be if Gal80p contacted Gal4p in, at least, two regions; one overlapping the activation domain (Wu et al., 1996), and one elsewhere in Gal4p. Activation by Gal3p may release the point of contact overlapping the activation domain while not affecting the other interaction site. Presumably, the second interaction site is close to the activation domain itself since the version of Gal4p used in these experiments (amino acids 1–93 fused to 768–881) is missing much of the full-length protein sequence.

Why is such a large molar excess of Gal3p required to observe activation of the Gal4p–Gal80p complex? We have found that a 30-fold molar excess of Gal3p is required to relieve the inhibitory effects of Gal80p. It is formally possible that much of the Gal3p we have purified is inactive. However, we do not believe this to be the case, since a weak interaction between Gal3p and Gal80p, judged by the efficiency of pull-down experiments from yeast extracts, has been observed in other experiments (Suzuki-Fujimoto et al., 1996; Zenke et al., 1996; Blank et al., 1997; Yano and Fukasawa, 1997). Gal4p is known to be present in yeast cells at very low levels (Johnston, 1987), but the levels of Gal3p in relation to Gal4p have not been studied. Our in vitro data suggest that Gal3p must be present in a considerable excess over Gal4p levels for the induction process to occur. It is possible, therefore, that the yeast cell uses this low-affinity interaction to modulate its response to galactose. The intracellular levels of galactose may have to exceed a threshold, to saturate the available Gal3p, before activation of GAL gene expression occurs.

Gal1p is also capable of activating the Gal4p–Gal80p complex, although less efficiently than Gal3p (Figure 2). It is possible that the relatively low levels of induction we observe using Gal1p could be due to the metabolism of galactose. Induction by Gal1p can directly explain how induction of the GAL genes occurs in the absence of Gal3p (Bhat and Hopper, 1991). When yeast cells lacking Gal3p are placed into media which contains galactose as the sole carbon source, the GAL genes will be activated 4–5 days later. It is possible that leaky expression of GAL1 will eventually build up sufficiently high levels of Gal1p to induce all of the GAL genes. With the exception of Gal3cp, we have been unable to observe galactose-independent activation of Gal4p–Gal80p. In vivo, over-production of either Gal3p or Gal1p gives rise to a constitutive GAL gene expression (Bhat and Hopper, 1992). We would anticipate that in vitro experiments performed with a higher ratio of Gal3p to Gal4p–Gal80p would yield galactose-independent expression.

Mapping the precise interactions between Gal3p and Gal80p, and the concomitant effects on Gal4p will be vital to understanding the molecular basis of the GAL genetic switch. We also need to understand the role of galactose and ATP in converting Gal3p into a protein able to interact with Gal80p. How does the binding of ATP and galactose to Gal3p allow the interaction with Gal80p? Now that we have been able to reconstitute the entire GAL genetic switch in vitro, experiments are in progress to elucidate the precise interactions and conformational changes that occur in this complex of proteins and small molecules during transcriptional induction.

Materials and methods

Top

Media and strains

Escherichia coli strain DH5alpha was used for all DNA manipulations. The following Saccharomyces cerevisiae strains were used: yeast nuclear extract was prepared from BJ2168 (MATalpha ura3 leu2 trp1 gal2 prb1 pep4 prc1) grown in YPD media (Ohashi et al., 1994); proteins were over-produced in strain MC2 (MATa trp1 ura3-52 leu2-3 prc1-407 prb1-112 pep4-3); genetic analysis was performed in strain JPY5 (MATalpha ura3-52 his3Delta200 leu2Delta1 trp1Delta63 lys2Delta385).

Selection of a GAL80 null mutation

JPY5 yeast strain deleted for endogenous GAL80, and harbouring a GAL1-lacZ reporter gene was transformed with plasmids bearing mutated versions of the GAL80 gene. Null alleles were isolated by searching for blue yeast colonies on plates containing 5-bromo-4-chloro-3-indoyl beta-D-galactopyranoside, supplemented with raffinose as the sole carbon source. GAL80G152D is a double point mutation (converting Gly152 to Asp, and producing a silent mutation at amino acid Lys287). The encoded protein only weakly interacts with Gal4p using in electrophoretic mobility shift assays (data not shown).

Plasmids

Gal80p, Gal3p and Gal1p yeast expression vectors were constructed using the polymerase chain reaction (PCR; oligonucleotide sequences are available on request). Amplified DNA fragments were cloned into pYEX-BX (Clontech), such that the genes were under the control of the CUP1 promoter. All plasmids were subjected to DNA sequencing to ensure that no mutations arose during the amplification process. Mutant versions of each protein were constructed by PCR-mediated site directed mutagenesis of the appropriate gene and insertion of the mutated product into pYEX-BX. Gal4p(1–93)+(768–881) was produced from the plasmid pRJR113 as described (Reece et al., 1993).

Protein purification

Plasmids over-producing Gal80p, Gal3p or Gal1p were transformed into MC2 yeast cells and grown in minimal media containing 2% glucose, but lacking leucine. Cells (3 L) were grown at 30°C until an absorbance of 1.0 at 600 nm was reached. Protein production was induced by the addition of CuSO4 to a final concentration of 0.5 mM, and cell growth continued for a further 23 h. Cells were harvested by centrifugation, washed in 40 ml of Buffer A (20 mM HEPES pH 8.0, 0.5 M NaCl, 1.4 mM beta-mercaptoethanol), centrifuged again and resuspended in 60 ml of Buffer A containing 10% glycerol and Complete protease inhibitors (Boehringer Mannheim). The cells were broken open using a bead-beater (Biospec Products) and centrifuged at 27 000 g for 20 min. The supernatant was further diluted with 140 ml Buffer A containing 10% glycerol before application to a 2 ml Ni2+-NTA-agarose column (Qiagen) and washed with 20 column volumes of Buffer B (20 mM HEPES pH 8.0, 150 mM NaCl, 20% glycerol, 30 mM imidazole). Protein was eluted from the column using Buffer B containing 250 mM imidazole. Fractions were analysed by SDS–PAGE, pooled, and dialysed against Buffer C (20 mM HEPES pH 7.5, 100 mM potassium glutamate, 10 mM MgSO4, 20% glycerol, 5 mM DTT). Each of the proteins were isolated with >95% purity. The purification of Gal4p(1–93)+(768–881) has been described previously (Reece et al., 1993).

In vitro transcription

In vitro transcription reactions were performed as previously described (Wu et al., 1996). Briefly, reactions (25 mul) contained 10 mM HEPES (pH 7.5), 10 mM MgSO4, 5 mM EGTA, 10% glycerol, 2.5 mM DTT, 100 mM potassium glutamate, 10 mM magnesium acetate, 2% polyvinylalcohol, 8 mM phosphoenolpyruvate, 0.31 nM of pG5E4 (Wu et al., 1996), 4 nM pGEM3Z (Promega), 3 mul yeast nuclear extract (60 mg/ml). Recombinant proteins were added together with, where appropriate, galactose (at the concentrations shown) and ATP (1.5 mM). The reactions were incubated for 10 min at 22°C. Nucleotide triphosphates were added (1 mM) and the reactions allowed to proceed for an additional 45 min at 22°C. Primer extension analysis of the RNA produced during these reactions was performed using an oligonucleotide complementary to the E4 coding sequence (5'-GCGGCAGCCTAACAGTCAGCCTTACCAGTA-3') (Lillie et al., 1986; Lin et al., 1988). The extension products were separated on a 10% polyacrylamide gel containing 1times TBE and 5 M urea, and analysed by autoradiography. Phosphoimage analysis was performed on a Fuji BAS2000 phosphoimager to quantitate the major E4 extension product.

Mobility shift assay

The DNA probe used was a double-stranded (5'-TCCGGAGGACTGTCCTCCGGT-3'), representing the consensus Gal4p binding (Wu et al., 1996). Reactions mixes (10 mul) contained 20 mM Tris–HCl (pH 7.5), 150 mM NaCl, 5% glycerol, 5 mM MgCl2, 10 muM ZnSO4, 50 pM 32P-labelled probe DNA, 100 mug/ml BSA and protein at the indicated concentrations. Reactions were incubated at 4°C for 20 min prior to loading onto a pre-electrophoresed 6% (w/v) polyacrylamide gel containing 45 mM tris base, 45 mM boric acid, 1 mM EDTA, 1% (w/v) glycerol. Electrophoresis was carried out at 20 V/cm for 2 h, and the gels were subjected to autoradiography.



Acknowledgements

Top

We thank Lutz Kapp and Karin Breunig for many useful discussions, and Paul Flynn, Alcide Barberis and Mark Ptashne for carefully reading the manuscript. We also thank Les Lockey for assistance with the figures. This work was supported by grants from the Medical Research Council and the Royal Society.

References

Top

Bhat PJ and Hopper JE (1991) The mechanism of inducer formation in gal3 mutants of the yeast galactose system is independent of normal galactose metabolism and mitochondrial respiratory function. Genetics, 128, 233–239. | PubMed | ISI | ChemPort |

Bhat PJ and Hopper JE (1992) Overproduction of the GAL1 or GAL3 protein causes galactose-independent activation of the GAL4 protein: evidence for a new model of induction for the yeast GAL/MEL regulon. Mol Cell Biol, 12, 2701–2707. | PubMed | ISI | ChemPort |

Bhat PJ, Oh D and Hopper JE (1990) Analysis of the GAL3 signal transduction pathway activating GAL4 protein-dependent transcription in Saccharomyces cerevisiae. Genetics, 125, 281–291. | PubMed | ISI | ChemPort |

Blank TE, Woods MP, Lebo CM, Xin P and Hopper JE (1997) Novel Gal3 proteins showing altered Gal80p binding cause constitutive transcription of Gal4p-activated genes in Saccharomyces cerevisiae. Mol Cell Biol, 17, 2566–2575. | PubMed | ISI | ChemPort |

Giniger E, Varnum SM and Ptashne M (1985) Specific DNA binding of GAL4, a positive regulatory protein of yeast. Cell, 40, 767–774. | Article | PubMed | ISI | ChemPort |

Hashimoto H, Kikuchi Y, Nogi Y and Fukasawa T (1983) Regulation of expression of the galactose gene cluster in Saccharomyces cerevisiae. Isolation and characterization of the regulatory gene GAL4. Mol Gen Genet, 191, 31–38. | PubMed | ISI | ChemPort |

Johnston M (1987) A model fungal gene regulatory mechanism: The GAL genes of Saccharomyces cerevisiae. Microbiol Rev, 51, 458–476. | PubMed | ISI | ChemPort |

Leuther KK and Johnston SA (1992) Nondissociation of GAL4 and GAL80 in vivo after galactose induction. Science, 256, 1333–1335. | PubMed | ISI | ChemPort |

Lillie JW, Green M and Green MR (1986) An adenovirus E1a protein region required for transformation and transcriptional repression. Cell, 46, 1043–1051. | Article | PubMed | ISI | ChemPort |

Lin Y-S, Carey MF, Ptashne M and Green MR (1988) GAL4 derivatives function alone and synergistically with mammalian activators in vitro. Cell, 54, 659–664. | Article | PubMed | ISI | ChemPort |

Lohr D, Venkov P and Zlantanova J (1995) Transcriptional regulation in the yeast GAL gene family: A complex genetic network. FASEB J, 9, 777–787. | PubMed | ISI | ChemPort |

Lue NF, Chasman DI, Buchman AR and Kornberg RD (1987) Interaction of GAL4 and GAL80 gene regulatory proteins in vitro. Mol Cell Biol, 7, 3446–3451. | PubMed | ISI | ChemPort |

Nogi Y and Fukasawa T (1984) Nucleotide sequence of the yeast regulatory gene GAL80. Nucleic Acids Res, 12, 9287–9298. | PubMed | ISI | ChemPort |

Nogi Y, Shimada H, Matsuzaki Y, Hashimoto H and Fukasawa T (1984) Regulation of expression of the galactose gene cluster in Saccharomyces cerevisiae. II. The isolation and dosage effect of the regulatory gene GAL80. Mol Gen Genet, 195, 29–34. | PubMed | ISI | ChemPort |

Ohashi Y, Brickman JM, Furman E, Middleton B and Carey M (1994) Modulating the potency of an activator in a yeast in vitro transcription system. Mol Cell Biol, 13, 2731–2739.

Reece RJ and Ptashne M (1993) Determinants of binding-site specificity among yeast C6 zinc cluster proteins. Science, 261, 909–911. | Article | PubMed | ISI | ChemPort |

Reece RJ and Platt A (1997) Signaling activation and repression of RNA polymerase II transcription in yeast. BioEssays, 19, 1001–1010. | PubMed | ISI | ChemPort |

Reece RJ, Rickles RJ and Ptashne M (1993) Overproduction and single-step purification of GAL4 fusion proteins from Escherichia coli. Gene, 126, 105–107. | Article | PubMed | ISI | ChemPort |

Rotman B and Spiegelman S (1953) The conversion of negatives to positives in 'slow' adapting populations of yeast. J Bacteriol, 66, 492–497. | PubMed | ISI | ChemPort |

Suzuki-Fujimoto T, Fukuma M, Yano K-I, Sakurai H, Vonika A, Johnston SA and Fukasawa T (1996) Analysis of the galactose signal transduction pathway in Saccharomyces cerevisiae: Interaction between Gal3p and Gal80p. Mol Cell Biol, 16, 2504–2508. | PubMed | ChemPort |

Wu Y, Reece RJ and Ptashne M (1996) Quantitation of putative activator-target affinities predicts transcriptional activating potentials. EMBO J, 15, 3951–3963. | PubMed | ISI | ChemPort |

Yano KI and Fukasawa T (1997) Galactose-dependent reversible interaction of Gal3p with Gal80p in the induction pathway of Gal4p-activated genes of Saccharomyces cerevisiae. Proc Natl Acad Sci USA, 94, 1721–1726. | Article | PubMed | ChemPort |

Zenke FT, Engles R, Vollenbroich V, Meyer J, Hollenberg CP and Breunig KD (1996) Activation of Gal4p by galactose-dependent interaction of galactokinase and Gal80p. Science, 272, 1662–1665. | Article | PubMed | ISI | ChemPort |